Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity-Reference-Cited by-同舟云学术

Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity

Published:2018-05-17 Issue:1 Volume:82 Page:149-157
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Anon Benjamin^ORCID,Largeau Bérenger,Girault Alban,Chantome Aurélie,Caulet Morgane,Perray Clémence,Moussata Driffa,Vandier Christophe,Barin-Le Guellec Chantal,Lecomte Thierry

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-018-3600-1/fulltext.html

Reference42 articles.

1. de Gramont A, Figer A, Seymour M et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938–2947

2. Andre T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343–2351

3. Gamelin L, Boisdron-Celle M, Morel A et al (2006) Oxaliplatin neurotoxicity. Bull Cancer 93(Suppl 1):S17–S22

4. Ta LE, Espeset L, Podratz J et al (2006) Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology 27:992–1002

5. Di Cesare Mannelli L, Pacini A, Micheli L et al (2014) Glial role in oxaliplatin-induced neuropathic pain. Exp Neurol 261:22–33

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustained Social Entrepreneurship: The Moderating Roles of Prior Experience and Networking Ability;Sustainability;2022-10-22

2. Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity;Methods in Molecular Biology;2022

3. Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development;Journal of Experimental & Clinical Cancer Research;2021-10-22

4. Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity;Journal of Personalized Medicine;2021-07-16

5. Chemotherapy-induced peripheral neuropathy: part 1—current state of knowledge and perspectives for pharmacotherapy;Pharmacological Reports;2020-05-11